FIELD: medicine; pharmaceuticals.
SUBSTANCE: group of inventions to detection of the main myelin protein. Composition for nerve labelling contains an agent of formula I or its salt:
and an aqueous pharmaceutical carrier containing PEG (polyethylene glycol) -300 in combination with polyvinylpyrrolidone or polyvinyl alcohol. Also disclosed is a method for imaging the main myelin protein in an open or minimally invasive surgical field by local administration of a composition for labelling nerves and a kit for providing a composition for labelling nerves.
EFFECT: group of inventions provides the best contrast of imaging.
17 cl, 11 dwg, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| OPTICAL AGENTS OF VISUALISATION | 2008 |
|
RU2475266C2 |
| MARKED PEPTIDES BINDING HEPATOCYTE GROWTH FACTOR (HGF) FOR VISUALISATION | 2008 |
|
RU2473361C9 |
| ANTIBODIES POLYPEPTIDES AND USE THEREOF | 2014 |
|
RU2687163C1 |
| OPTICAL VISUALISATION AGENTS | 2008 |
|
RU2484111C9 |
| FLUORESCENT CONJUGATES AND USE THEREOF FOR TUMOR DIAGNOSTICS | 2016 |
|
RU2720976C2 |
| PEPTIDE COMPOUNDS | 2005 |
|
RU2393167C2 |
| PEPTIDYL-DIACYLGLYCERIDES | 2009 |
|
RU2545347C2 |
| APTAMERS FOR INTRAOPERATIVE STAINING OF GLIOBLASTOMA AND METHOD OF THEIR USE | 2023 |
|
RU2826956C1 |
| COMPOSITION FOR OPTICAL VISUALIZATION, METHOD OF ITS PRODUCTION AND USE | 2019 |
|
RU2802481C2 |
| INHIBITORS OF RECEPTORS OF TYPE 2 VESSEL ENDOTHELIUM GROWTH FACTOR | 2004 |
|
RU2402567C2 |
